TimeScale Financial’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

TimeScale Financial’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$174	Sell	72 -1	-1%	-$4	﹤0.01%	607
2023 Q1	$591	Hold	73	–	–	﹤0.01%	561
2022 Q4	$1.01K	Hold	73	–	–	﹤0.01%	503
2022 Q3	$1K	Hold	73	–	–	﹤0.01%	533
2022 Q2	$3K	Hold	73	–	–	﹤0.01%	421
2022 Q1	$3K	Hold	73	–	–	﹤0.01%	428
2021 Q4	$3K	Hold	73	–	–	﹤0.01%	426
2021 Q3	$5K	Hold	73	–	–	﹤0.01%	385
2021 Q2	$6K	Hold	73	–	–	﹤0.01%	372
2021 Q1	$5K	Hold	73	–	–	﹤0.01%	391
2020 Q4	$2K	Hold	73	–	–	﹤0.01%	387
2020 Q3	$4K	Hold	73	–	–	﹤0.01%	377
2020 Q2	$3K	Hold	73	–	–	﹤0.01%	385
2020 Q1	$1K	Hold	73	–	–	﹤0.01%	403
2019 Q4	$3K	Hold	73	–	–	﹤0.01%	463
2019 Q3	$4K	Hold	73	–	–	﹤0.01%	424
2019 Q2	$7K	Buy	+73	New	+$8.88K	﹤0.01%	392

Other funds holding DMK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

TimeScale Financial's DMK Position: Q2 2023 in Review

TimeScale Financial reduced its DMK Pharmaceuticals Corporation Common Stock (DMK) stake by 1.4% in Q2 2023, selling an estimated $4 and leaving 72 shares worth $174. The position accounts for ﹤0.01% of the portfolio, ranked #607.

TimeScale Financial first reported a position in DMK in Q2 2019 and has held it in 17 quarters since. The position peaked at $7K in Q2 2019. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

TimeScale Financial held 72 shares of DMK Pharmaceuticals Corporation Common Stock worth $174 as of Q2 2023.
TimeScale Financial sold 1 DMK Pharmaceuticals Corporation Common Stock share in Q2 2023, an estimated $4.
DMK Pharmaceuticals Corporation Common Stock made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #607 holding.
TimeScale Financial first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2019 and has held it in 17 quarters since.
TimeScale Financial's DMK Pharmaceuticals Corporation Common Stock position peaked at $7K in Q2 2019.
22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.